TALTZ 80 mg/mL
ixekizumab · INJECTION, SOLUTION · Eli Lilly and Company
1 Recall on Record
Plain English
TALTZ is a injection, solution containing ixekizumab at 80 mg/mL, taken subcutaneous. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- TALTZ
- Generic Name
- ixekizumab
- NDC Code (Product)
0002-1445- Manufacturer
- Eli Lilly and Company
- Strength
- 80 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125521
- Drug Class
- Interleukin-17A Antagonist [EPC]
- Marketing Start
- 03/22/2016
Recall History
1 Recall on Record
Class II04/03/2018
Kroger Specialty Pharmacy, Inc.
Lack of Processing Controls.
TerminatedVoluntary: Firm initiated
Frequently Asked Questions
What is TALTZ used for?
TALTZ contains ixekizumab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is TALTZ a controlled substance?
TALTZ is not classified as a controlled substance by the DEA.
What is the generic name for TALTZ?
The generic name for TALTZ is ixekizumab. There are no other listed brand versions of ixekizumab.
What is the NDC code for TALTZ 80 mg/mL?
The NDC (National Drug Code) for TALTZ 80 mg/mL is 0002-1445, listed by Eli Lilly and Company.
Other TALTZ Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)